| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 02/15/1989 | EP0303028A1 Method for preparing single chain urokinase | 
| 02/15/1989 | EP0302925A1 A method for producing factor viii in high yield | 
| 02/14/1989 | US4804676 Propioxatins a and b | 
| 02/14/1989 | US4804626 Using immobilized monoclonal antibodies | 
| 02/14/1989 | CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers | 
| 02/09/1989 | WO1989001050A1 Selective amplification of target polynucleotide sequences | 
| 02/09/1989 | WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain | 
| 02/09/1989 | WO1989001040A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same | 
| 02/09/1989 | WO1989001036A1 Recombinant dna expression vectors | 
| 02/09/1989 | WO1989001029A1 Airlift insect cell culture | 
| 02/09/1989 | WO1989001028A1 Serum free media for the growth of insect cells and expression of products thereby | 
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use | 
| 02/09/1989 | WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents | 
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 | 
| 02/08/1989 | EP0302838A2 Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme | 
| 02/08/1989 | EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells | 
| 02/08/1989 | EP0302442A2 Vibriolysin coupling process | 
| 02/08/1989 | EP0302381A1 A fused gene having aequorin gene linked to a functional B-galactosidase gene | 
| 02/08/1989 | EP0302103A1 Colony stimulating factors having reduced levels of carbohydrate | 
| 02/08/1989 | EP0145775B1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION | 
| 02/08/1989 | CN1030939A Promoter for expression of exogenous dna in methyltrophic bacteria, process for preparing same and theiruse | 
| 02/07/1989 | US4803169 Assay for human breast cancer | 
| 02/07/1989 | US4803155 Monoclonal antibodies to Sclerotinia homoeocarpa | 
| 02/07/1989 | CA1249785A1 Method for selectively increasing the ratio of single major components of teicoplanin a2 complex | 
| 02/07/1989 | CA1249781A1 Methods of concentrating ligands and active membranes used therefor | 
| 02/01/1989 | EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections | 
| 02/01/1989 | EP0301961A1 Specific secretion-excretion-antigens from toxoplasma gondii, expression products therefrom, production processes therefor and their diagnostic and prophylactic applications | 
| 02/01/1989 | EP0301954A2 Cloning method and expression of genes constituting functional organised structures | 
| 02/01/1989 | EP0301670A1 Kluyveromyces as a host strain | 
| 02/01/1989 | EP0301669A1 DNA constructs containing a Kluyveromyces alpha-factor leader sequence for directing secretion of heterologous derivatives | 
| 02/01/1989 | EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH | 
| 02/01/1989 | EP0301484A1 PTH modifications and therapeutic compositions containing them or consisting of them | 
| 02/01/1989 | EP0301289A1 Humaner Papillomvirus Typ 41 | 
| 02/01/1989 | EP0301247A2 De-mannosyl teicoplanin derivatives | 
| 02/01/1989 | EP0138948B1 Dna sequence encoding an exo-signal | 
| 02/01/1989 | CN1030766A Enkastine-glycopeptide of action having inhibitory encephalinase, process for preparing them and pharamaceutical use | 
| 01/31/1989 | US4801687 Monoclonal antibody purification process using protein A | 
| 01/31/1989 | US4801686 Suspension, microbial cells, breaking, extraction | 
| 01/31/1989 | US4801542 Expression of biologically active PDGF analogs in eucaryotic cells | 
| 01/26/1989 | WO1989000695A1 Method for the diagnosis of infections with detection of lipopolysaccharide antigens | 
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same | 
| 01/26/1989 | WO1989000603A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein | 
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof | 
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside | 
| 01/26/1989 | WO1989000579A1 Purification of gm-csf | 
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof | 
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor | 
| 01/25/1989 | EP0300487A2 Enzymatically inactive, immunologically active beta-galactosidase muteins | 
| 01/25/1989 | EP0300425A2 Method for the production of proteins in a soluble form | 
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens | 
| 01/25/1989 | EP0300168A2 Process for the glutathione synthesis in yeast | 
| 01/25/1989 | EP0300031A1 Immunosuppressive peptides and methods of use | 
| 01/25/1989 | EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity | 
| 01/25/1989 | CN1030645A Immunodiagnostic assays using chimeric antigens | 
| 01/25/1989 | CN1030611A Monoclonal antibody specific for adhesion function domain of phagocyte cell surface protein | 
| 01/25/1989 | CN1030610A Monoclonal antibody specific to common determinant site of neutrophils and eosinophils | 
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it | 
| 01/25/1989 | CN1030589A Urinary follicle stimulating hormone | 
| 01/24/1989 | US4800157 Process for producing the A-21978C antibiotics | 
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life | 
| 01/18/1989 | EP0299828A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications | 
| 01/18/1989 | EP0299810A1 Process for the production of polypeptides by recombinant DNA | 
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) | 
| 01/18/1989 | EP0299746A1 Purification of GM-CSF | 
| 01/18/1989 | EP0299707A2 Glycopeptide antibiotics | 
| 01/18/1989 | EP0299706A2 Nonglycosylated plasminogen activator and method of preparation | 
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use | 
| 01/18/1989 | EP0299303A2 Eucaryotic expression vectors with multimeric enhancer subelements, process for their preparation and use | 
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens | 
| 01/18/1989 | EP0299206A2 Recombinant human ADF | 
| 01/18/1989 | EP0299127A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein | 
| 01/18/1989 | EP0299108A1 DNA-molecules coding for FMDH control regions and structured gene for a protein having FMDH-activity and their uses | 
| 01/18/1989 | EP0299057A1 Potentiation of cytotoxic conjugates | 
| 01/18/1989 | CN1030443A Multivalent meningococcal class 1 outer-membrane protein vaccine | 
| 01/17/1989 | US4798807 Monoclonal antibodies and method for detecting dioxins and dibenzofurans | 
| 01/17/1989 | US4798791 Vector for high level gene expression | 
| 01/17/1989 | US4798790 Monoclonal antibody specific for a pigmentation associated antigen | 
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods | 
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion | 
| 01/12/1989 | WO1989000198A1 Recombinant fibroblast growth factors | 
| 01/12/1989 | WO1989000196A1 Virus proteins having reduced o-linked glycosylation | 
| 01/12/1989 | WO1989000192A1 Production of kallikrein | 
| 01/12/1989 | WO1989000190A1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein | 
| 01/12/1989 | WO1989000169A1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils | 
| 01/12/1989 | WO1989000163A1 Vaccines against animal parasitic nematodes | 
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 | 
| 01/12/1989 | WO1989000048A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications | 
| 01/12/1989 | WO1988009818A3 Growth hormone receptor | 
| 01/11/1989 | EP0298807A1 Method for the production of stable cell lines from transgenic animals for the production of specific proteins; tumour cell lines and proteins obtained | 
| 01/11/1989 | EP0298723A1 Recombinant fibroblast growth factors | 
| 01/11/1989 | EP0298633A2 Synthetic polypeptides | 
| 01/11/1989 | EP0298450A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions | 
| 01/11/1989 | EP0298088A1 Production and diagnostic use of antibodies against pancreatic alpha-amylase | 
| 01/11/1989 | CN1030256A Methods and materials for h1v detection and therapy | 
| 01/10/1989 | US4797929 Word recognition in a speech recognition system using data reduced word templates | 
| 01/10/1989 | US4797474 Solubilization of protein aggregates | 
| 01/10/1989 | US4797473 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins | 
| 01/10/1989 | US4797370 Antigens, bonding, immunology | 
| 01/10/1989 | US4797356 Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays | 
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |